BIOMAT Database Logo BIOMAT Database Logo

Brain chemistry and central nervous system drugs. 1988

R I Brinkworth, and E J Lloyd, and P R Andrews
School of Pharmaceutical Chemistry, Victorian College of Pharmacy Ltd., Parkville, Victoria, Australia.

UI MeSH Term Description Entries
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

R I Brinkworth, and E J Lloyd, and P R Andrews
Central nervous system drugs.
March 2019, Nursing,
R I Brinkworth, and E J Lloyd, and P R Andrews
Antiretroviral drugs and the central nervous system.
October 1998, AIDS (London, England),
R I Brinkworth, and E J Lloyd, and P R Andrews
Drugs and the developing central nervous system.
January 1980, Pharmacology & therapeutics,
R I Brinkworth, and E J Lloyd, and P R Andrews
Discontinued drugs 2007: central and peripheral nervous system drugs.
February 2009, Expert opinion on investigational drugs,
R I Brinkworth, and E J Lloyd, and P R Andrews
[Drug actions: central nervous system drugs].
March 1973, [Kango] Japanese journal of nursing,
R I Brinkworth, and E J Lloyd, and P R Andrews
Chemistry of disease of the central nervous system.
March 1960, Metabolism: clinical and experimental,
R I Brinkworth, and E J Lloyd, and P R Andrews
Central Nervous System Agents in Medicinal Chemistry. Editorial.
March 2010, Central nervous system agents in medicinal chemistry,
R I Brinkworth, and E J Lloyd, and P R Andrews
Discontinued drugs in 2006: central and peripheral nervous system drugs.
November 2007, Expert opinion on investigational drugs,
R I Brinkworth, and E J Lloyd, and P R Andrews
Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?
January 2006, Current medicinal chemistry,
R I Brinkworth, and E J Lloyd, and P R Andrews
Central nervous system pharmacology of antileukemic drugs.
January 1989, The American journal of pediatric hematology/oncology,
Copied contents to your clipboard!